Below you will find current and archived press releases for your associated company. Navigate by selecting the year in the list below and click on the press release you want to read. Distribution takes place with a maximum of five minutes delay from press release.

Press Release

Brighter's nomination committee for the Annual General Meeting 2019.

In accordance with the guidelines established at the AGM 2018, the nomination committee for Brighter's AGM 2019 has now been appointed.
The c...

Brighter recruits Global Product Manager - Diabetes.

Brighter recruits Thor Sundsvik as Global Product Manager - Diabetes effective immediately. In this new role at Brighter, Thor will oversee and dr...

Interim report July-September 2018.

The full Interim report is available on Brighter's website https://brighter.se. The Interim report is also attached as a pdf file to this press re...

Brighter appoints Deputy Managing Director of the company's UAE subsidiary.

Hamza Moftah has been appointed Deputy Managing Director of Brighter's subsidiary in the United Arab Emirates, established August 2018 in collabor...

Brighter draws down the eighth tranche under the financing agreement with L1 Capital and issues additional free warrants to its shareholders.

Brighter has called upon a eighth Tranche of SEK 10 million in line with the terms from the financing agreement communicated on the 26thof April 2...

Brighter receives SEK 0.8 M through exercise of warrants.

The exercise period for Brighter's warrants of series TO3 is now completed. The company thereby strengthens its financing with SEK 837 628, repres...

Brighter receives SEK 29M from the company's management, board and key personnel.

The exercise period for Brighter's management, board and key personnel incentive programs 2014/2017 Series I & II and 2015/2018 Series I & II is n...

The Actiste companion applications and The Benefit Loop are now CE certified.

The mobile applications and digital infrastructure of Brighter's award-winning service for insulin treated diabetics - Actiste® Diabetes Managemen...

Brighter strengthens its financing with SEK 2,9M through exercise of warrants.

The exercise period for Brighter's warrants of series TO4 is now completed. The company thereby strengthens its financing with SEK 2 893 140, repr...

Brighter's management and key personnel incentive programs are expected to strengthen the company's financing with SEK 29M.

Brighter's CEO and COO intend to utilize their parts of the company's incentive program (2014/2017 Series II and 2015/2018 Series II). The CEO's h...

Brighter and AFAQ have established a corporation in the UAE.

Brighter AB (publ) and AFAQ Group L.L.C. have successfully established a jointly owned corporation in Dubai, United Arab Emirates.
The new co...

Interim report April-June 2018.

The full Interim report is available on Brighter's website www.brighter.se. The Interim report is also attached as a pdf file to this press releas...

Conversion of warrants series 2014 and 2015.

On the occasion of the Company's rights issues recalculation has been executed in accordance with the terms referring to the subscription price an...

Brighter announces Actiste pricing.

Brighter's award-winning service for insulin-treated diabetics - Actiste® Diabetes Management as a Service - is initially introduced to the market...

The European Patent Office intend to grant Brighter's patent for AI-powered monitoring of medical devices.

The European Patent Office intend to grant Brighter's European patent application 16744322.5 regarding Artificial Intelligence-driven medical devi...

Brighter draws down the seventh tranche under the financing agreement with L1 Capital and issues additional free warrants to its shareholders.

Brighter has called upon a seventh Tranche of SEK 5 million in line with the terms from the financing agreement communicated on the 26thof April 2...

Dr. Teddy Batanghari, Kairos Healthcare's Co-Founder and former CEO of Summit Healthcare, becomes Senior Advisor to Brighter.

Brighter AB (publ) is pleased to announce that Dr Teddy Batanghari joins as Senior Advisor. Dr. Batanghari will advise Brighter on various matters...

Brighter defines market vision for Actiste until 2023 on 5 continents.

Brighter AB (publ) has developed estimates of segment size and ideal target markets for the company's diabetes solution Actiste® Diabetes Manageme...

Brighter's Board of Directors has decided to initiate the process to apply for listing its shares on a regulated market.

At the board meeting on July 5th2018, the Board of Directors Brighter AB (publ) formally decided to initiate the process of applying for listing i...

Brighter and AFAQ initiate partnership to launch Actiste in the GCC.

Brighter AB (publ) and AFAQ Group L.L.C. have entered a partnership to establish a company based in the United Arab Emirates and introduce Actiste...

Communication from the AGSM of Brighter AB (publ).

Brighter's Annual General Shareholders Meeting was held on Wednesday May 16, 2018 at the company's address in Stockholm, Kista.
The annual gene...

Brighter Interim report January-March 2018: Momentum towards Actiste delivery continues.

The full Interim report is available on Brighter's website www.brighter.se. The Interim report is also attached as a pdf file to this press releas...

Brighter draws down the sixth tranche under the financing agreement with L1 Capital and issues additional free warrants to its shareholders.

Brighter has called upon a sixth Tranche of SEK 10 million in line with the terms from the financing agreement communicated on the 26thof April 20...

Brighter strengthens its financing with 0,9 MSEK through exercise of warrants.

The second exercise period for Brighter's warrants of series TO3 is now completed. The company thereby strengthens its financing with 884 444 SEK,...

Catarina Ihre proposed as a new member of Brighter's Board of Directors.

At Brighter's upcoming annual general shareholders meeting, the Company's Nomination Committee will propose changes to the Board of Directors, wit...

Official notification of the annual general meeting.

Brighter AB (publ) will hold its Annual General Meeting (AGM) on Wednesday 16th of May 2018, at 11:00, at the offices of Brighter AB, Norgegatan 2...

Barbro Fridén proposed as new Chairman of Brighter's Board.

At Brighter's upcoming shareholders meeting, the Board of Directors Nomination Committee will propose changes to the Board of Directors, with Barb...

Brighter's diabetes solution Actiste wins the Red Dot Award for good design and quality.

Brighter's unique diabetes solution Actiste, introduced to the market in December 2017, has been awarded the prestigious Red Dot Award, in the Pro...

Brighter strengthens its financing with 672 TSEK through exercise of warrants.

The first exercise period for Brighter's warrants of series TO4 is now completed. The company thereby strengthens its financing with 672 TSEK, rep...

Brighter's Actiste nominated to Sweden's most prestigious Design Award.

Brighter's solution Actiste® have been nominated to Design-S Swedish Design Awards 2018, in the category Industrial and Product Design B2B. Design...

Brighter and FRISQ initiate partnership to strengthen the infrastructure for digital healthcare.

Brighter and FRISQ have initiated a strategic partnership to strengthen the infrastructure and increase the information flow in the healthcare sec...

Brighters year-end report 2017.

From development to commercialization.
The full Year End Report is available on Brighter's website www.brighter.se. A pdf copy is also attached...

Update on the Actiste CE certification process.

During the past year, Brighter has been working on finalizing and CE certifying the company's diabetes solution Actiste (http://actiste.com/). Due...

Brighter appoints Petra Kaur as Vice President of Marketing & Communications.

Petra Kaur Ljungman, who has been a member of Brighter's Board since 2014, is now formally appointed as Vice President of Marketing & Communicatio...

Brighter, Ericsson and Arkessa show Actiste at MWC in Barcelona.

Brighter participates in the Swedish delegation of approximately 160 companies at Mobile World Congress (MWC) in Barcelona. The fair is the world'...

First exercise period of TO4 starts today.

As part of our financing strategy and the agreement with L1 Capital, Brighter has distributed free warrants to the company's shareholders to reduc...

New date for publication of year-end results and updated financial calendar.

The publication of Brighter's year-end report 2017 is moved from February 23 to March 23 due to implementation of a new accounting principle (IFRS...

The European Patent Office has granted Brighter's patent application.

The European Patent Office has granted Brighter's patent application no. 14864054.3, regarding method and device for logging drug injections made ...

Change in number of shares in Brighter AB.

Conversion of convertible notes into shares under the Convertible Notes issued under the financing agreement announced on April 26.
Change in...

QUICK FACTS

Sector:: Life Science
Website:: www.brighterir.com
List:: Sweden First North
Market Cap:: 574,2
Ticker:: BRIG
Next Event:: -

New Event

ABGSC Investor Days
Tuesday 8 - Wednesday 9 March 2022

CONFIRMED COMPANIES:

Addtech	Formpipe
Adtraction	GOMSpace
Avensia	IRLAB Therapeutics
Axactor	Maha Energy
Bergs Timber	Nordic Waterproofing
Boule Diagnostics	Physitrack
Dedicare	Seafire
Fastpartner	Swedencare

Latest company news

Gaming Innovation Group

Gaming Innovation Group - Successful placement of a SEK 100 million bond tap issue

Gaming Innovation Group

Gaming Innovation Group - Successful placement of a SEK 100 million bond tap issue

Swedencare

Swedencare intends to carry out a directed share issue

Swedencare

Swedencare AB (publ) acquires leading American pet supplement company NaturVet

Swedencare

Swedencare AB (publ) acquires the Italian pet healthcare company Innovet

About ABGSC

ABG Sundal Collier is the independent, Nordic investment banking powerhouse, developed over 30 years, founded on a hard working partnership culture and the ability to attract top talent.

Our strategy is to be an advisor and an intermediary, and the core product offering comprise corporate advisory services, corporate financing services and investor research and brokerage services.

Our corporate advisory team offers access to a broad financial and industrial network and unparalleled transaction experience. We provide financing to corporates through our superior Nordic and international distribution platform, and we are optimally structured for naturally matching trading flows, delivering best execution for clients.

The group employ approx. 250 staff working from the Nordic offices in Norway, Sweden and Denmark and in the offices in the key international markets US, UK and Germany. ABGSC ambition is to be the preferred Nordic Investment bank. We are committed to delivering long term superior value for all key stakeholders by:

Providing the best advice in relation to strategic challenges
Providing the optimal external corporate financing
Improving clients’ investment return Being “the place to be” for talented staff
Running a cost focused and highly profitable operation

Brighter Follow

Brighter

Press Release